Common side effects during this period can include nausea, diarrhea, constipation, and vomiting
"We're not only lowering the cost of medications, we're also connecting members to real, human care: specialists in obesity and diabetes, clinical pharmacists, and ongoing nutritional support with registered dietitiansall from the comfort of home." Key Benefits for Employers: Virtual medical care from 9amHealth's expert Care Team, including Obesity Medicine physicians and endocrinologists Access to first-generation medications used in the treatment of obesity at transparent, discounted prices through www.costplusdrugs.com Coverage for branded obesity GLP-1s at fixed monthly costs with variable cost share through 9amHealth's manufacturer programs At-home lab testing, prescription delivery, and 24/7 clinical support Scalable solution for managing obesity, diabetes, and related chronic conditions in employer populations This collaboration arrives at a critical time, as more employers look to offer clinically effective and financially sustainable weight-loss coverage
Ozempic was approved for the management of type 2 diabetes mellitus in adults in addition to a reduced-calorie diet and exercise
The study included 2539 adults with a body mass index (BMI) of 30 or higher or 27 or higher with weight-related complications
Similarly, a recently approved antidiabetic agent of the same drug family, semaglutide, has been assessed in a double-blind phase 2 RCT in 320 patients with NASH without DM2, given subcutaneously once daily, at various doses, for 72 weeks (NCT02970942)
Product range and specialization Metabolic peptides offered: Beyond retatrutide, Paradigm Peptides stocks semaglutide, tirzepatide, and other weight loss peptides for comparative research
